# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate need for non-invasive methods to track hepatic mitochondrial metabolism

## BRIEF SUMMARY OF THE INVENTION

- describe composition of isotopically labelled compounds
- outline method of measuring metabolic rates

## DETAILED DESCRIPTION OF THE INVENTION

- describe PINTA method for non-invasive assessment of hepatic glucose production, anaplerosis, and citrate synthase flux

### Compositions

- define isotopically labelled glucose and C3 compound compositions

### Methods

- describe method of non-invasively measuring hepatic mitochondrial oxidation flux and pyruvate carboxylase flux
- administer isotopically labelled glucose, C3 compound, and beta-hydroxybutyric acid to subject
- collect and analyze biological sample to assess rate of endogenous glucose production
- determine pyruvate carboxylase flux and hepatic mitochondrial oxidation flux
- optionally administer 2H-labelled glycerol and 13C-labelled palmitate to assess rate of lipolysis

### Kits

- describe kit comprising composition of isotopically labelled glucose and C3 compound

### Dosing and Administration

- describe pharmaceutical composition and administration methods

### Definitions

- define terms used in the invention
- explain meaning of "a" and "an"
- define "abnormal" in context of organisms
- explain meaning of "about" in measurable values
- define "co-administered" and "co-administration"
- define "composition" and "pharmaceutical composition"
- define various terms used in the invention

## EXAMPLES

- provide illustrative examples

### Example 1: Non-Invasive Assessment of Hepatic Mitochondrial Metabolism by Positional Isotopomer NMR Tracer Analysis

- describe animal studies
- describe human studies
- outline tracer studies
- derive flux modeling equations
- calculate VPC/VCS ratio
- expand derivation of VPC/VCS taking into account pyruvate recycling and other minor fluxes
- relate Î±-ketoglutarate and OAA labeling
- derive equations for positional isotopomer NMR tracer analysis
- describe application of MIDA analysis for calculating VPC/VEGP
- introduce non-invasive assessment of hepatic mitochondrial metabolism
- describe flux calculations and equations
- outline analytical methods for GC/MS, LC/MS-MS, and NMR analyses
- present liver glycogen content analysis
- describe statistical analysis
- validate PINTA method with ex vivo NMR analysis
- demonstrate applicability of PINTA method in humans
- validate sensitivity of PINTA method to expected changes in fluxes
- discuss advantages and limitations of PINTA method

### Example 2: Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation

- introduce glucose metabolism in starvation
- describe shift from glucose to fat metabolism
- motivate effect of starvation on glucose and fat metabolism
- introduce PINTA method to assess in vivo rates of mitochondrial pyruvate carboxylase flux and mitochondrial oxidation
- describe animal studies and experimental design
- outline tracer infusions and pharmacologic manipulations
- describe glucose clamps and alanine replacement studies
- outline flux measurements and biochemical analysis
- describe tissue analysis and quantification methods
- summarize statistical analysis and data presentation
- introduce starvation model
- describe glucose and fatty acid metabolism changes
- analyze leptin's role in glucose and fatty acid metabolism
- investigate leptin replacement's effects on glucose and fatty acid metabolism
- examine leptin's role in WAT lipolysis and hepatic acetyl-CoA content
- study the impact of CPT-1 inhibition on glucose and fatty acid metabolism
- analyze the role of WAT lipolysis in maintaining euglycemia
- investigate the effects of mifepristone on glucose and fatty acid metabolism
- discuss the significance of leptin-mediated glucose-fatty acid cycle in starvation
- describe glucose-fatty acid cycle in starvation
- examine role of hepatic glycogenolysis in glucose production
- investigate effect of glycogen phosphorylase inhibitor on glucose production
- analyze impact of reductions in hepatic glycogenolysis on HPA axis activity
- examine role of leptin in regulating WAT lipolysis and hepatic gluconeogenesis
- investigate effect of leptin infusion on WAT lipolysis and hepatic gluconeogenesis
- examine role of insulinopenia in regulating WAT lipolysis and hepatic gluconeogenesis
- analyze impact of reductions in alanine turnover on hepatic gluconeogenesis
- summarize new concepts regarding leptin biology and regulation of substrate metabolism

### Example 3: Glucagon Allosterically Stimulates Gluconeogenesis by InsP3R-I Mediated Intrahepatic Lipolysis

- motivate glucagon's role in hyperglycemia
- describe glucagon's stimulation of gluconeogenesis
- outline animal protocols and in vivo studies
- detail in vivo studies and PINTA analysis
- calculate glucose turnover and flux ratios
- describe experimental design
- detail biochemical analysis methods
- outline in vitro studies procedures
- summarize statistical analysis approach
- discuss selected results and implications
- interpret findings in context of glucagon's effect on gluconeogenesis
- describe glucagon's effect on hepatic glucose production
- investigate glucagon's stimulation of intrahepatic lipolysis
- examine glucagon's effect on hepatic mitochondrial oxidation
- study glucagon's role in regulating hepatic gluconeogenesis
- analyze glucagon's effect on hepatic acetyl-CoA content
- investigate glucagon's effect on pyruvate carboxylase flux
- examine glucagon's effect on hepatic insulin resistance
- summarize glucagon's mechanisms of action

